InvestorsHub Logo
Followers 8
Posts 478
Boards Moderated 0
Alias Born 03/12/2016

Re: None

Wednesday, 02/20/2019 12:43:36 PM

Wednesday, February 20, 2019 12:43:36 PM

Post# of 462100

Alzheimer Society International Congress 2019
ASIC 2019
February 18 - 21, 2019
San Francisco Airport Crowne Plaza


Anavex is spreading the word again tomorrow at another venue at
10:30 AM PST

Federico Goodsaid,3Harald Hampel,1
Mohammad Afshar2, Frédéric Parmentier2,
Coralie Williams2, Adrien Etcheto2,
Christopher U Missling4
1Department of Neurology, Sorbonne
University, Paris, France, 2Ariana Pharma,
Paris, France, 3Regulatory Pathfnders LLC,
San Francisco, CA, 4Anavex Life Sciences
Corp., New York, NY
“Longitudinal 148-Week Extension Study for
ANAVEX®2-73 Phase 2a Alzheimer’s Disease
Demonstrates Maintained Activities of Daily
Living Score (ADCS-ADL) and Reduced
Cognitive Decline (MMSE) for Patient Cohort
on Higher Drug Concentration and Confrms
Role of Patient Selection Biomarkers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News